75 Results

People

  1. Wang
    Wang
  2. Riviere
    Riviere
  3. Brentjens
    Brentjens
  4. Sadelain
    Sadelain
  5. Park
    Park
  6. Senechal
    Senechal
  7. Curran
    Curran
  8. Bernal
    Bernal
  9. Purdon
    Purdon
  10. Halton
    Halton

Groups

  1. Adult Leukemia (75)
  2. Center for Hematologic Malignancies (75)
  3. Department of Medicine (75)
  4. Hematologic Malignancies Research (75)
  5. Hematologic Malignancies, Division of (75)
  6. GSK Faculty (74)
  7. Sloan Kettering Institute Faculty (66)
  8. Molecular Pharmacology and Chemistry Program Faculty (65)
  9. Pediatrics, Department of (32)
  10. Stem Cell Transplantation and Cellular Therapy Service (29)
  1. "Hematologic Malignancies Research"
  2. "Center for Hematologic Malignancies"
  3. "Xiuyan Wang"
  4. "Adult Leukemia"
Formats
  1. Meeting Abstract (53)
  2. Journal Article (21)
  3. Research Letter (1)
Groups
  1. Adult Leukemia (75)
  2. Center for Hematologic Malignancies (75)
  3. Department of Medicine (75)
  4. Hematologic Malignancies Research (75)
  5. Hematologic Malignancies, Division of (75)
  6. GSK Faculty (74)

More Groups

People
  1. Xiuyan Wang (75)
  2. Isabelle Riviere (73)
  3. Michel Sadelain (65)
  4. Renier Brentjens (65)
  5. Jae Park (64)
  6. Brigitte Senechal (35)

More People

Years
  1. 2023 (6)
  2. 2022 (5)
  3. 2021 (6)
  4. 2020 (2)
  5. 2019 (8)
  6. 2018 (8)

More Years

Publications
  1. Blood (27)
  2. Journal of Clinical Oncology (11)
  3. Molecular Therapy (7)
  4. Haematologica (5)
  5. Hematological Oncology (3)
  6. Science Translational Medicine (3)

More Publications

Publishers
  1. American Society of Hematology (27)
  2. American Society of Clinical Oncology (11)
  3. Nature Publishing Group (10)
  4. American Association for Cancer Research (5)
  5. Ferrata Storti Foundation (5)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (75)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of cell therapy product characteristics in patient response to TAK-940 (CD19(T2)28z1xx chimeric antigen receptor (CAR) T): Biomarker analyses from a phase i study in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Sundaresan, V.; Senechal, B.; Wang, X.; Kashyap, S.; Tong, E.; Joshi, A.; Dash, A.; Sellner, L.; Chen, S.; McAvoy, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Devlin, S. M.; Valtis, Y. K.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E.; Liotta, K.; Yu, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Cooperative CAR targeting to selectively eliminate AML and minimize escape
    Journal Article

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; de Stanchina, E.; Lopez, M.; Ng, M. R.; Fraser, K.; Subklewe, M.; more...
    Cancer Cell (2023)

    Fulltext@MSK | Save
  • Validation of a high-sensitivity assay for detection of chimeric antigen receptor T-cell vectors using low-partition digital PCR technology
    Journal Article

    Arcila, M. E.; Patel, U.; Momeni-Boroujeni, A.; Yao, J.; Chan, R.; Chan, J.; Rijo, I.; Yu, W.; Chaves, N.; Patel, H.; more...
    Journal of Molecular Diagnostics (2023)

    Fulltext@MSK | Save
  • Characterizing the relationship between cellular kinetics and response to support dosing recommendations for Cd19-targeted 19(T2)28z1xx cell therapy
    Meeting Abstract

    Li, J.; Singh, R.; Dey, A.; Sellner, L.; Liu, R.; Dash, A.; Park, J.; Palomba, M.; Mansilla-Soto, J.; Senechal, B.; more...
    Clinical Pharmacology & Therapeutics (2023)

    Fulltext@MSK | Save
  • A phase I study of CD19‐targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory diffuse large B‐cell lymphoma
    Meeting Abstract

    Palomba, M. L.; Riviere, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Cathcart, E. R.; Liotta, K.; Li, J.; Sellner, L.; Sadelain, M.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: Initial experience in two clinical trials
    Meeting Abstract

    Qualls, D.; Monette, S.; Sethi, S.; Dogan, A.; Roshal, M.; Senechal, B.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1XX CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Rivière, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Bermudez, V. P.; Cathcart, E. R.; Liotta, K.; Joseph, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; Rivière, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • GPRC5D-targeted CAR T cells for myeloma
    Journal Article

    Mailankody, S.; Devlin, S. M.; Landa, J.; Nath, K.; Diamonte, C.; Carstens, E. J.; Russo, D.; Auclair, R.; Fitzgerald, L.; Cadzin, B.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save